Tempest Reports Second Quarter 2022 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Tempest Therapeutics, Inc. (TPST) Tops Q2 EPS by 13c
August 15, 2022 8:07 AM EDTTempest Therapeutics, Inc. (NASDAQ: TPST) reported Q2 EPS of ($0.79), $0.13 better than the analyst estimate of ($0.92).
For earnings history and earnings-related data on Tempest Therapeutics, Inc. (TPST) click here.
... More